Regulatory approval status across Asia-Pacific

Hydrix Medical is actively working with regulatory bodies across Asia-Pacific to finalise approvals and reimbursement pathways to the GUARDIAN for patients throughout the region.

*Regulatory pathway applications are planned for Japan, Hong Kong and Indonesia.
**Medicines and Medical Devices Safety Authority (MMDSA).
***WAND notified August 2021.

Contact Hydrix Medical to get in touch with a representative for your country.